(Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) is a chimeric peptide combining VIP and GRF domains with targeted substitutions that tune charge and hydrophobicity. The modified sequence enables analysis of dual receptor interactions and cross-family signaling. Its architecture is useful for mapping domains responsible for G protein activation. Researchers apply it in studies of peptide hormone synergy and receptor selectivity.
CAT No: V1321
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.